SKI Market

Indian Indices

Nifty

26,175.75 -27.20
(-0.10%)

Sensex

85,641.90 -64.77
( -0.08%)

Bank Nifty

59,681.35 -71.35
( -0.12%)

Nifty IT

37,549.75 144.25
( 0.39%)

Global Indices

Nasdaq

47,322.89 -414.54
(-0.87%)

Dow Jones

6,835.10 -34.99
(-0.51%)

Hang Seng

49,313.21 -940.70
(-1.87%)

Nikkei 225

9,706.88 -13.63
(-0.14%)

Forex

USD-INR

89.30 0.10
(0.11%)

EUR-INR

103.54 0.22
(0.21%)

GBP-INR

118.23 0.49
(0.41%)

JPY-INR

0.57 0.00
(0.17%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Macobs Technologies Ltd

Industry : Trading

BSE Code

ISIN Demat

Book Value()

92764

INE0R0J01010

28.6811908

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

MACOBSTECH

83.96

217.94

EPS(TTM)

Face Value()

Div & Yield %

2.65

Back

Relonchem receives UK MHRA's marketing approval for two products

Nov 17,2025

Marksans Pharma announced that its wholly owned subsidiary Relonchem in UK has received Marketing Authorization for its following products from UK MHRA:

1. Mefenamic Acid 250 mg Film-Coated Tablets
2. Mefenamic Acid 500 mg Film-Coated Tablets

26,175.75 -27.20 (-0.10%)

85,641.90 -64.77 ( -0.08%)

59,681.35 -71.35 ( -0.12%)

37,549.75 144.25 ( 0.39%)

47,322.89 -414.54 (-0.87%)

6,835.10 -34.99 (-0.51%)

49,313.21 -940.70 (-1.87%)

9,706.88 -13.63 (-0.14%)

89.30 0.10 (0.11%)

103.54 0.22 (0.21%)

118.23 0.49 (0.41%)

0.57 0.00 (0.17%)